463 related articles for article (PubMed ID: 28335700)
1. Cochlear implants in the management of hearing loss in Neurofibromatosis Type 2.
Harris F; Tysome JR; Donnelly N; Durie-Gair J; Crundwell G; Tam YC; Knight RD; Vanat ZH; Folland N; Axon P
Cochlear Implants Int; 2017 May; 18(3):171-179. PubMed ID: 28335700
[TBL] [Abstract][Full Text] [Related]
2. Cochlear implantation and auditory brainstem implantation in neurofibromatosis type 2.
Peng KA; Lorenz MB; Otto SR; Brackmann DE; Wilkinson EP
Laryngoscope; 2018 Sep; 128(9):2163-2169. PubMed ID: 29573425
[TBL] [Abstract][Full Text] [Related]
3. Auditory brainstem implants in NF2 patients: results and review of the literature.
Sanna M; Di Lella F; Guida M; Merkus P
Otol Neurotol; 2012 Feb; 33(2):154-64. PubMed ID: 22246383
[TBL] [Abstract][Full Text] [Related]
4. English consensus protocol evaluating candidacy for auditory brainstem and cochlear implantation in neurofibromatosis type 2.
Tysome JR; Axon PR; Donnelly NP; Evans DG; Ferner RE; O'Connor AF; Freeman SR; Gleeson M; Halliday D; Harris F; Jiang D; Kerr R; King A; Knight RD; Lloyd SK; Macfarlane R; Mannion R; Mawman D; O'Driscoll M; Parry A; Ramsden J; Ramsden R; Rutherford SA; Saeed SR; Thomas N; Vanat ZH
Otol Neurotol; 2013 Dec; 34(9):1743-7. PubMed ID: 24136318
[TBL] [Abstract][Full Text] [Related]
5. Cochlear implantation in patients with neurofibromatosis type 2: variables affecting auditory performance.
Carlson ML; Breen JT; Driscoll CL; Link MJ; Neff BA; Gifford RH; Beatty CW
Otol Neurotol; 2012 Jul; 33(5):853-62. PubMed ID: 22664900
[TBL] [Abstract][Full Text] [Related]
6. Cochlear implantation after radiosurgery for vestibular schwannoma.
Patel NS; Carlson ML; Link MJ; Neff BA; Van Gompel JJ; Driscoll CLW
J Neurosurg; 2021 Jul; 135(1):126-135. PubMed ID: 34250789
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Cochlear Implantation in Neurofibromatosis Type 2 Related Hearing Loss.
Sobczak G; Marchant W; Misurelli S; Pyle GM; Gubbels S; Roche J
Ann Otol Rhinol Laryngol; 2023 Mar; 132(3):284-293. PubMed ID: 35450430
[TBL] [Abstract][Full Text] [Related]
8. Ipsilateral Cochlear Implantation in the Presence of Observed and Irradiated Vestibular Schwannomas.
Urban MJ; Moore DM; Kwarta K; Leonetti J; Rajasekhar R; Gluth MB; Wiet RM
Ann Otol Rhinol Laryngol; 2020 Dec; 129(12):1229-1238. PubMed ID: 32551844
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of cochlear implantation in patients with neurofibromatosis type 2.
North HJ; Mawman D; O'Driscoll M; Freeman SR; Rutherford SA; King AT; Hammerbeck-Ward C; Evans DG; Lloyd SK
Cochlear Implants Int; 2016 Jul; 17(4):172-177. PubMed ID: 27691934
[TBL] [Abstract][Full Text] [Related]
10. Auditory brainstem implants for neurofibromatosis type 2.
Colletti L; Shannon R; Colletti V
Curr Opin Otolaryngol Head Neck Surg; 2012 Oct; 20(5):353-7. PubMed ID: 22886036
[TBL] [Abstract][Full Text] [Related]
11. Comparing Speech Recognition Outcomes Between Cochlear Implants and Auditory Brainstem Implants in Patients With NF2-Related Schwannomatosis.
Dornhoffer JR; Plitt AR; Lohse CM; Driscoll CLW; Neff BA; Saoji AA; Van Gompel JJ; Link MJ; Carlson ML
Otol Neurotol; 2024 Jan; 45(1):29-35. PubMed ID: 37875011
[TBL] [Abstract][Full Text] [Related]
12. Auditory outcomes in tumor vs. nontumor patients fitted with auditory brainstem implants.
Colletti V
Adv Otorhinolaryngol; 2006; 64():167-185. PubMed ID: 16891842
[TBL] [Abstract][Full Text] [Related]
13. Hearing restoration in NF2 patients and patients with vestibular schwannoma in the only hearing ear: report of two cases.
Ozdek A; Bayır O; Dönmez T; Ozışık P; Sahin M; Tulgar M; Tatar EÇ; Korkmaz MH
Am J Otolaryngol; 2014; 35(4):538-41. PubMed ID: 24746329
[TBL] [Abstract][Full Text] [Related]
14. Auditory brainstem implant in neurofibromatosis type 2 and non-neurofibromatosis type 2 patients.
Grayeli AB; Kalamarides M; Bouccara D; Ambert-Dahan E; Sterkers O
Otol Neurotol; 2008 Dec; 29(8):1140-6. PubMed ID: 18849886
[TBL] [Abstract][Full Text] [Related]
15. Ipsilateral cochlear implantation after cochlear nerve preserving vestibular schwannoma surgery in patients with neurofibromatosis type 2.
Lloyd SK; Glynn FJ; Rutherford SA; King AT; Mawman DJ; O'Driscoll MP; Evans DG; Ramsden RT; Freeman SR
Otol Neurotol; 2014 Jan; 35(1):43-51. PubMed ID: 24335931
[TBL] [Abstract][Full Text] [Related]
16. Beneficial auditory and cognitive effects of auditory brainstem implantation in children.
Colletti L
Acta Otolaryngol; 2007 Sep; 127(9):943-6. PubMed ID: 17712673
[TBL] [Abstract][Full Text] [Related]
17. Cochlear implant failure: is an auditory brainstem implant the answer?
Colletti V; Carner M; Miorelli V; Guida M; Colletti L; Fiorino F
Acta Otolaryngol; 2004 May; 124(4):353-7. PubMed ID: 15224852
[TBL] [Abstract][Full Text] [Related]
18. Auditory rehabilitation of patients with neurofibromatosis Type 2 by using cochlear implants.
Roehm PC; Mallen-St Clair J; Jethanamest D; Golfinos JG; Shapiro W; Waltzman S; Roland JT
J Neurosurg; 2011 Oct; 115(4):827-34. PubMed ID: 21761973
[TBL] [Abstract][Full Text] [Related]
19. Cochlear implantation in patients with neurofibromatosis type 2 and bilateral vestibular schwannoma.
Lustig LR; Yeagle J; Driscoll CL; Blevins N; Francis H; Niparko JK
Otol Neurotol; 2006 Jun; 27(4):512-8. PubMed ID: 16791043
[TBL] [Abstract][Full Text] [Related]
20. Surgical management of vestibular schwannomas and hearing rehabilitation in neurofibromatosis type 2.
Tysome JR; Macfarlane R; Durie-Gair J; Donnelly N; Mannion R; Knight R; Harris F; Vanat ZH; Tam YC; Burton K; Hensiek A; Raymond FL; Moffat DA; Axon PR
Otol Neurotol; 2012 Apr; 33(3):466-72. PubMed ID: 22334163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
